President Trump has made lowering drug prices and reducing healthcare costs for Americans a top priority of his second term, along with encouraging more biopharmaceutical investment and innovation in the U.S. Citizens Against Government Waste suggests that he can achieve both objectives without imposing price controls, which includes Most Favored Nation (MFN) polices, reforming the […]
Improper payments have long been an avoidable drain on the federal budget and are often prominently featured as an example of wasteful spending. It is therefore not surprising that in the August 12, 2025, Government Accountability Office (GAO) updated report on open recommendations to improve government operations, reducing fraud and improper payments was first on […]
The Inflation Reduction Act creates instability in the Medicare Part D Program.
The Inflation Reduction Act will ultimately raise drug costs and reduce future cures.
Taxpayers and beneficiaries should be concerned with the Biden administration’s proposed cuts to Medicare Advantage.
IRA drug price controls will devastate future drug development, resulting in more lives lost.
House Democrats’ new bill on price controls will devastate future drug development and raise costs.
The Center for Medicare and Medicaid Innovation (CMMI) sounds like it should be involved in ground-breaking, state-of-the-art healthcare projects and programs. However, the center was created in the Patient Protection and Affordable Care Act (ACA), better known as Obamacare, which in and of itself raises red flags. CMMI is run by the Centers for Medicare […]
Centers for Medicare and Medicaid Services (CMS) Office of the Inspector General (OIG) recently exposed vulnerabilities that end up costing taxpayers hundreds of billions in wasteful spending due to erroneous and sloppy billing, and outright fraud. The OIG’s October 7, 2016 report documented that even though The Medicare Access and Children’s Health Insurance Program (CHIP) Reauthorization […]
Citizens Against Government Waste’s February Waste Watcher, “Obamacare’s Cerberus,” discussed concerns with three organizations created under the Affordable Care Act (ACA), or Obamacare. They are the Patient Centered Outcome Research Institute (PCORI), the Independent Payment Advisory Board (IPAB), and the Center for Medicare and Medicaid Innovation (CMMI.) All have the capability to develop into government rationing boards.
